1/15
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
how do glucocorticoids decrease inflammation?
inhibit NF-κB DNA binding activity (transcription factor with central role in inflammation)
IκB inhibits activation of NF-κB
lipocortin inhibits phospholipase A2 activity: block conversion of phospholipids → arachidonic acid

effects of glucocorticoids on inflammation/immune response
anti-inflammatory activities (NF-κB)
decrease prostaglandin synthesis
inhibit IgE-mediated histamine release
impair leukocyte phagocytosis
inhibit fibroblast proliferation
inhibit lymphocytes
proliferation
induce apoptosis
adverse GI effects of glucocorticoids
GI ulceration via PLA2 inhibition
inhibit COX-1 & COX-2
↑ gastric acid secretion (parietal cells)
↓ gastric mucosal turnover
↑ risk with concurrent NSAID use
adverse endocrine effects of glucocorticoids (dogs)
iatrogenic hyperadrenocorticism
hepatomegaly
deposition of hepatic glycogen
elevated SAP & GGT
polyuria/polydipsia
inhibition of vasopressin (ADH)
increased lipolysis & visceral adipogenesis
potbelly, altered fat distribution
muscle atrophy
↓ protein synthesis
alopecia
↓ collagen synthesis
impaired fibroblast proliferation
skin thins & easily stretches
impaired wound healing
adverse endocrine effects of glucocorticoids (cats)
diabetes mellitus
hyperglycemia
increased gluconeogenesis
increased glycogenolysis
insulin resistance
via free fatty acid mobilization & lipolysis
other adverse endocrine effects of glucocorticoids
HPA axis suppression
increased exogenous corticosteroids
adrenal gland atrophy
requires tapering of steroids to avoid hypoadrenocorticism crisis
what is a potential adverse consequence of immunosuppression by glucocorticoids?
opportunistic infections
bacterial
fungal
more common with
chronic use
high doses
adverse cardiovascular effects of glucocorticoids
hypertension
congestive heart failure
steroid formulations with mineralocorticoid activity
sodium & water retention → volume overload
decreased production of vasodilatory PGs → increased vasoconstriction
hydrocortisone (receptor activity, duration, onset, formulations)
least potent GC
mineralocorticoid receptor (MR) activity
rapid onset; short acting
formulations: IV, topical (OTC), oral
what is the difference between prednisone & prednisolone? which species is prednisolone used in?
prednisone is a prodrug
prednisolone = active drug
GC & MR activity
poor liver conversion to prednisolone
cats: prednisolone preferred to prednisone
horses: prednisolone required
dexamethasone receptor activity
GC
no mineralocorticoid activity → no salt + water retention
budensonide uses
oral enteric-coated formulation with high first pass metabolism (liver)
potential for less steroid-related side effects
↓ induction of steroid ALP (dogs)
↓ PU/PD, polyphagia, panting
documented HPA suppression (dogs)
alternative treatment for inflammatory diseases
gastrointestinal
liver
fluticasone uses
causes bronchodilation
allergic bronchitis (dogs)
feline asthma
high topical (inhalant) potency; low systemic absorption
side effects: HPA axis suppression can occur
triamcinolone formulation
topical glucocorticoid
DOCP (desoxycorticosterone pivalate) receptor activity, uses
long-acting injectable mineralocorticoid
dosed ~q 25-28d
dose & dosing interval adjusted based on serum electrolytes
NO GR activity
requires adjunct use of GCs for full treatment of hypoadrenocorticism
indications
hypoadrenocorticism (dogs)
hyponatremia & hyperkalemia
fludrocortisone receptor activity, use, side effects
short-acting mineralocorticoid
daily administration
glucocorticoid activity
PU/PD at doses required to normalize Na+ & K+ levels
side effects:
PU/PD
increased risk of infections
muscle wasting
insulin resistance